Q2 Earnings Estimate for CME Group Issued By Zacks Research

CME Group Inc. (NASDAQ:CMEFree Report) – Investment analysts at Zacks Research raised their Q2 2025 earnings per share estimates for CME Group in a report released on Tuesday, February 4th. Zacks Research analyst T. De now expects that the financial services provider will post earnings of $2.50 per share for the quarter, up from their previous forecast of $2.45. The consensus estimate for CME Group’s current full-year earnings is $10.18 per share. Zacks Research also issued estimates for CME Group’s Q3 2025 earnings at $2.53 EPS, Q4 2025 earnings at $2.55 EPS, FY2025 earnings at $10.14 EPS, Q2 2026 earnings at $2.60 EPS and Q3 2026 earnings at $2.37 EPS.

CME has been the subject of a number of other reports. Barclays raised their price objective on CME Group from $231.00 to $257.00 and gave the stock an “equal weight” rating in a research report on Monday, December 9th. Oppenheimer increased their price objective on CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a report on Thursday, October 24th. Royal Bank of Canada restated a “sector perform” rating and issued a $235.00 price objective on shares of CME Group in a report on Monday, January 6th. Deutsche Bank Aktiengesellschaft lowered their target price on shares of CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a research report on Monday, November 11th. Finally, Citigroup downgraded shares of CME Group from a “buy” rating to a “neutral” rating and decreased their price objective for the stock from $255.00 to $250.00 in a report on Monday, January 6th. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $229.27.

Read Our Latest Stock Report on CME Group

CME Group Stock Up 0.2 %

Shares of CME Group stock opened at $244.83 on Friday. CME Group has a 12-month low of $190.70 and a 12-month high of $249.02. The firm has a market capitalization of $88.23 billion, a PE ratio of 25.74, a price-to-earnings-growth ratio of 5.37 and a beta of 0.57. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. The stock’s fifty day moving average is $235.34 and its 200-day moving average is $223.63.

Institutional Investors Weigh In On CME Group

Several large investors have recently bought and sold shares of the company. Czech National Bank grew its position in shares of CME Group by 6.9% in the 3rd quarter. Czech National Bank now owns 73,355 shares of the financial services provider’s stock valued at $16,186,000 after purchasing an additional 4,742 shares during the period. Atomi Financial Group Inc. raised its holdings in shares of CME Group by 59.1% during the third quarter. Atomi Financial Group Inc. now owns 2,778 shares of the financial services provider’s stock worth $613,000 after acquiring an additional 1,032 shares during the period. Brookstone Capital Management lifted its position in CME Group by 10.4% in the 3rd quarter. Brookstone Capital Management now owns 33,730 shares of the financial services provider’s stock valued at $7,443,000 after acquiring an additional 3,175 shares in the last quarter. CWM LLC boosted its stake in CME Group by 50.7% in the 3rd quarter. CWM LLC now owns 34,056 shares of the financial services provider’s stock worth $7,514,000 after purchasing an additional 11,462 shares during the period. Finally, Wedmont Private Capital increased its holdings in CME Group by 6.4% during the 3rd quarter. Wedmont Private Capital now owns 2,512 shares of the financial services provider’s stock worth $557,000 after purchasing an additional 152 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

CME Group announced that its Board of Directors has initiated a share buyback plan on Thursday, December 5th that permits the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization permits the financial services provider to buy up to 3.4% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s board believes its shares are undervalued.

CME Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Friday, March 7th will be paid a $1.25 dividend. This is a positive change from CME Group’s previous quarterly dividend of $1.15. The ex-dividend date of this dividend is Friday, March 7th. This represents a $5.00 annualized dividend and a yield of 2.04%. CME Group’s dividend payout ratio is presently 48.37%.

About CME Group

(Get Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Read More

Earnings History and Estimates for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.